KRRO - Korro Bio, Inc.

QQQ $ 472.78 $ -3.19 (-0.67 %)

DIA $ 416.60 $ -1.39 (-0.33 %)

SPY $ 562.19 $ -2.94 (-0.52 %)

TLT $ 100.93 $ -0.46 (-0.45 %)

GLD $ 237.38 $ -0.60 (-0.25 %)

Previous Close

$ 40.86

Open

$ 40.59

Bid

$ 40.40 x 100

Ask

-- x --

Day's Range

$ 36.84 - $ 41.01

52 Week Range

$ 0.18 - $ 97.91

Volume

58,500

Average Volume

Market Cap

379.95M

Beta (5Y Monthly)

$ 8.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-26-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-12-2023	03-31-2023	10-Q
7	03-10-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	03-15-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-29-2021	12-31-2020	10-K
16	11-16-2020	09-30-2020	10-Q
17	08-12-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-26-2020	12-31-2019	10-K
20	11-18-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

gold-edges-lower-us-homebuilder-sentiment-rises-for-september

Gold Edges Lower; US Homebuilder Sentiment...
09/17/2024 18:31:07

crude-oil-gains-over-1-us-business-inventories-increase-in-july

Crude Oil Gains Over 1%; US Business Inven...
09/17/2024 16:16:13

HC Wainwright & Co. Reiterates Buy on Korr...
09/17/2024 10:57:20

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $100 price target.

Korro Bio shares are trading higher after ...
09/16/2024 12:26:42

Korro Bio Announces Collaboration With Nov...
09/16/2024 12:12:03

Partnership leverages Korro's proprietary OPERATM platform to enable its oligonucleotide-directed RNA edits into two undisc...

gene-editing-korro-bios-preclinical-data-best-in-class-analyst-initiates-with-outperform-rating

Gene Editing Korro Bio's Preclinical Data ...
08/14/2024 18:21:10

William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst r...

RBC Capital Maintains Outperform on Korro ...
08/14/2024 15:35:25

RBC Capital analyst Luca Issi maintains Korro Bio (NASDAQ:KRRO) with a Outperform and lowers the price target from $105 to $95.

William Blair Initiates Coverage On Korro ...
08/14/2024 12:06:36

William Blair analyst Myles Minter initiates coverage on Korro Bio (NASDAQ:KRRO) with a Outperform rating.

HC Wainwright & Co. Reiterates Buy on Korr...
08/14/2024 12:01:39

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $100 price target.

Korro Bio Q2 EPS $(2.43) Misses $(2.40) Es...
08/13/2024 20:14:41

Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.43) per share which missed the analyst consensus estimate of $(2.40) b...

Korro Bio Joins Russell 2000, Russell 3000...
07/01/2024 12:06:40

HC Wainwright & Co. Reiterates Buy on Korr...
05/21/2024 10:36:32

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Korro Bio (NASDAQ:KRRO) with a Buy and maintains $100 price target.

Korro Presents Additional Preclinical Data...
05/20/2024 18:33:01

KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels ...

HC Wainwright & Co. Maintains Buy on Korro...
05/15/2024 15:11:37

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and lowers the price target fro...

BMO Capital Maintains Outperform on Korro ...
05/15/2024 13:02:21

BMO Capital analyst Kostas Biliouris maintains Korro Bio (NASDAQ:KRRO) with a Outperform and maintains $120 price target.

Korro Bio Q1 2024 Adj EPS $(2.44) Beats $(...
05/14/2024 20:20:30

Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.44) per share which beat the analyst consensus estimate of $(2.51) by ...

Korro Announces $70M Private Placement
04/18/2024 12:32:40

Financing led by Deep Track Capital with participation from other leading healthcare investorsPro-forma cash and cash equivalen...

HC Wainwright & Co. Maintains Buy on Korro...
03/28/2024 10:24:42

HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and raises the price target fro...

Piper Sandler Maintains Overweight on Korr...
03/27/2024 16:46:12

Piper Sandler analyst Yasmeen Rahimi maintains Korro Bio (NASDAQ:KRRO) with a Overweight and maintains $180 price target.

RBC Capital Maintains Outperform on Korro ...
03/27/2024 14:38:00

RBC Capital analyst Luca Issi maintains Korro Bio (NASDAQ:KRRO) with a Outperform and raises the price target from $70 to $90.